Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycine-N-acyltransferase like 1 pseudogene 1 (GLYATL1P1) is a nonfunctional genomic DNA segment that shares sequence similarity with the glycine-N-acyltransferase like 1 gene but lacks the ability to encode a functional protein product. Pseudogenes arise from gene duplication or retrotransposition events but acquire disabling mutations that prevent them from being expressed or functioning like their ancestral genes. While the majority of pseudogenes have no known biological function, a few can be transcribed and may play rare regulatory roles through RNA mechanisms, such as acting as microRNA decoys or sources of small interfering RNAs, but there is no evidence that GLYATL1P1 fulfills such a role. Therefore, GLYATL1P1 is not considered a receptor, enzyme, or other classical drug target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine-N-acyltransferase like 1 pseudogene 1 (GLYATL1P1).